A Dose Escalation Study to Assess the Efficacy and Safety of Bradanicline in Subjects With Refractory Chronic Cough
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2019
Price : $35 *
At a glance
- Drugs Bradanicline (Primary)
- Indications Cough
- Focus Proof of concept; Therapeutic Use
- Sponsors Attenua
- 18 Jun 2019 Status changed from recruiting to completed.
- 14 Nov 2018 According to an Attenua Inc media release, first patient has been treated in this trial.
- 05 Nov 2018 Status changed from not yet recruiting to recruiting.